Showing results (271-280 of 595) with videos related to

Sort By:
Pageof 60
Arthritis and Rheumatism|July 9, 2003
Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacyJacques-Eric Gottenberg, Florence Merle-Vincent, Fabrice Bentaberry, et al.
International Journal of Cardiology|August 21, 2016
N-terminal pro-brain natriuretic peptide is a strong predictor of mortality in systemic sclerosisYannick Allanore, Andras Komocsi, Serena Vettori, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 10, 2019
Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung DiseaseMuriel Elhai, Anna Maria Hoffmann-Vold, Jérôme Avouac, et al.
The Lancet. Rheumatology|January 26, 2024
Digital ulcers: should debridement be a standard of care in systemic sclerosis?Michael Hughes, Begonya Alcacer-Pitarch, Yannick Allanore, et al.
Rheumatology (Oxford, England)|June 9, 2023
Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung diseaseYannick Allanore, Dinesh Khanna, Vanessa Smith, et al.
Seminars in Arthritis and Rheumatism|May 1, 2018
Practical suggestions on intravenous iloprost in Raynaud's phenomenon and digital ulcer secondary to systemic sclerosis: Systematic literature review and expert consensusFrancesca Ingegnoli, Tommaso Schioppo, Yannick Allanore, et al.
Autoimmunity Reviews|January 21, 2021
Real life picture of the use of intravenous immunoglobulins in idiopathic inflammatory myopathies: Results of a multicentric studySimone Barsotti, Ilaria Cavazzana, Giovanni Zanframundo, et al.
European Journal of Internal Medicine|June 17, 2020
Screening for pulmonary arterial hypertension in systemic sclerosis: A systematic literature reviewCosimo Bruni, Giacomo De Luca, Maria-Grazia Lazzaroni, et al.
Joint Bone Spine|December 27, 2022
Risk stratification using anti-citrullinated peptide antibodies (ACPA) in polyarticular subtypes of juvenile idiopathic arthritis in adulthoodAlice Combier, Camelia Frantz, Julien Wipff, et al.
Annals of the Rheumatic Diseases|February 26, 2016
Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosisMatthieu Ponsoye, Camelia Frantz, Nadira Ruzehaji, et al.
Pageof 60